Natera Inc has a consensus price target of $103.06 based on the ratings of 17 analysts. The high is $142 issued by Jefferies on June 3, 2024. The low is $68 issued by Morgan Stanley on November 10, 2023. The 3 most-recent analyst ratings were released by Jefferies, Piper Sandler, and BTIG on June 3, 2024, May 14, 2024, and May 13, 2024, respectively. With an average price target of $129 between Jefferies, Piper Sandler, and BTIG, there's an implied 21.58% upside for Natera Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/03/2024 | Buy Now | 33.84% | Jefferies | Tycho Peterson | → $142 | Initiates | → Buy | Get Alert |
05/14/2024 | Buy Now | 13.1% | Piper Sandler | David Westenberg | $110 → $120 | Maintains | Overweight | Get Alert |
05/13/2024 | Buy Now | 17.81% | BTIG | Mark Massaro | $100 → $125 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | 22.53% | Canaccord Genuity | Kyle Mikson | $100 → $130 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | 29.12% | TD Cowen | Dan Brennan | $123 → $137 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | 10.27% | Baird | Catherine Ramsey | $99 → $117 | Maintains | Outperform | Get Alert |
04/15/2024 | Buy Now | -5.75% | Goldman Sachs | Matthew Sykes | $90 → $100 | Maintains | Buy | Get Alert |
04/08/2024 | Buy Now | 10.27% | Craig-Hallum | Alexander Nowak | → $117 | Assumes | → Buy | Get Alert |
04/05/2024 | Buy Now | 13.1% | Bernstein | Eve Burstein | → $120 | Upgrade | Market Perform → Outperform | Get Alert |
03/06/2024 | Buy Now | 3.68% | Piper Sandler | David Westenberg | $70 → $110 | Maintains | Overweight | Get Alert |
02/29/2024 | Buy Now | -15.17% | Goldman Sachs | Matthew Sykes | $80 → $90 | Maintains | Buy | Get Alert |
02/29/2024 | Buy Now | -5.75% | Canaccord Genuity | Kyle Mikson | $87 → $100 | Maintains | Buy | Get Alert |
02/27/2024 | Buy Now | -15.17% | BTIG | Mark Massaro | $85 → $90 | Maintains | Buy | Get Alert |
02/20/2024 | Buy Now | -19.89% | Raymond James | Andrew Cooper | $68 → $85 | Downgrade | Strong Buy → Outperform | Get Alert |
01/30/2024 | Buy Now | -26.48% | Stephens & Co. | Mason Carrico | → $78 | Reiterates | Overweight → Overweight | Get Alert |
01/30/2024 | Buy Now | -24.6% | Goldman Sachs | Matthew Sykes | $64 → $80 | Maintains | Buy | Get Alert |
01/29/2024 | Buy Now | -24.6% | Goldman Sachs | Matthew Sykes | $64 → $80 | Maintains | Buy | Get Alert |
01/17/2024 | Buy Now | -26.48% | Stephens & Co. | Mason Carrico | → $78 | Reiterates | Overweight → Overweight | Get Alert |
12/29/2023 | Buy Now | -19.89% | BTIG | Mark Massaro | $75 → $85 | Maintains | Buy | Get Alert |
12/29/2023 | Buy Now | -39.68% | Goldman Sachs | Matthew Sykes | $56 → $64 | Maintains | Buy | Get Alert |
12/14/2023 | Buy Now | -34.02% | Guggenheim | Subbu Nambi | → $70 | Initiates | → Buy | Get Alert |
12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel | — | Initiates | → Outperform | Get Alert |
12/12/2023 | Buy Now | -18% | TD Cowen | Dan Brennan | $82 → $87 | Maintains | Outperform | Get Alert |
11/13/2023 | Buy Now | -35.91% | Raymond James | Andrew Cooper | → $68 | Upgrade | Outperform → Strong Buy | Get Alert |
11/10/2023 | Buy Now | -35.91% | Morgan Stanley | Tejas Savant | $70 → $68 | Maintains | Overweight | Get Alert |
11/09/2023 | Buy Now | -34.02% | UBS | Elizabeth Garcia | $76 → $70 | Maintains | Buy | Get Alert |
10/20/2023 | Buy Now | -50.99% | Goldman Sachs | Matthew Sykes | $60 → $52 | Maintains | Buy | Get Alert |
10/16/2023 | Buy Now | -34.02% | Piper Sandler | David Westenberg | $80 → $70 | Maintains | Overweight | Get Alert |
09/28/2023 | Buy Now | -54.76% | Bernstein | Eve Burstein | → $48 | Initiates | → Market Perform | Get Alert |
08/08/2023 | Buy Now | -24.6% | Piper Sandler | David Westenberg | $70 → $80 | Maintains | Overweight | Get Alert |
08/07/2023 | Buy Now | -34.02% | Morgan Stanley | Tejas Savant | $72 → $70 | Maintains | Overweight | Get Alert |
08/04/2023 | Buy Now | -34.02% | Credit Suisse | Dan Leonard | → $70 | Reiterates | Outperform → Outperform | Get Alert |
07/24/2023 | Buy Now | -43.45% | Goldman Sachs | Matthew Sykes | $70 → $60 | Maintains | Buy | Get Alert |
07/21/2023 | Buy Now | -43.45% | Goldman Sachs | Matthew Sykes | $70 → $60 | Maintains | Buy | Get Alert |
05/30/2023 | Buy Now | -34.02% | Piper Sandler | David Westenberg | $80 → $70 | Maintains | Overweight | Get Alert |
05/10/2023 | Buy Now | -24.6% | Piper Sandler | David Westenberg | → $80 | Maintains | Overweight | Get Alert |
05/10/2023 | Buy Now | -34.02% | Credit Suisse | Dan Leonard | $65 → $70 | Maintains | Outperform | Get Alert |
05/10/2023 | Buy Now | -34.02% | Goldman Sachs | Matthew Sykes | $80 → $70 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | -37.79% | Baird | Catherine Ramsey | $65 → $66 | Maintains | Outperform | Get Alert |
05/05/2023 | Buy Now | -28.37% | UBS | Elizabeth Garcia | → $76 | Initiates | → Buy | Get Alert |
03/03/2023 | Buy Now | -35.91% | Raymond James | Andrew Cooper | $58 → $68 | Maintains | Outperform | Get Alert |
03/02/2023 | Buy Now | -32.14% | Morgan Stanley | Tejas Savant | $70 → $72 | Maintains | Overweight | Get Alert |
03/01/2023 | Buy Now | -38.74% | Credit Suisse | Dan Leonard | $55 → $65 | Maintains | Outperform | Get Alert |
01/18/2023 | Buy Now | -45.33% | Raymond James | Andrew Cooper | → $58 | Upgrade | Market Perform → Outperform | Get Alert |
01/17/2023 | Buy Now | -34.02% | Piper Sandler | David Westenberg | → $70 | Maintains | Overweight | Get Alert |
11/14/2022 | Buy Now | -48.16% | Credit Suisse | Dan Leonard | $70 → $55 | Maintains | Outperform | Get Alert |
08/25/2022 | Buy Now | -34.02% | Credit Suisse | Dan Leonard | → $70 | Initiates | → Outperform | Get Alert |
08/17/2022 | Buy Now | -34.02% | Piper Sandler | David Westenberg | $60 → $70 | Maintains | Overweight | Get Alert |
08/05/2022 | Buy Now | -5.75% | JP Morgan | Julia Qin | $80 → $100 | Maintains | Overweight | Get Alert |
05/16/2022 | Buy Now | -43.45% | Piper Sandler | David Westenberg | $75 → $60 | Maintains | Overweight | Get Alert |
05/09/2022 | Buy Now | -34.02% | Morgan Stanley | Tejas Savant | $110 → $70 | Maintains | Overweight | Get Alert |
04/25/2022 | Buy Now | -49.1% | Stephens & Co. | Mason Carrico | → $54 | Initiates | → Overweight | Get Alert |
04/19/2022 | Buy Now | -24.6% | Goldman Sachs | Matthew Sykes | $90 → $80 | Maintains | Buy | Get Alert |
03/21/2022 | Buy Now | -34.02% | Piper Sandler | David Westenberg | $80 → $70 | Maintains | Overweight | Get Alert |
03/08/2022 | Buy Now | -15.17% | Goldman Sachs | Matthew Sykes | → $90 | Initiates | → Buy | Get Alert |
02/28/2022 | Buy Now | 3.68% | Morgan Stanley | Tejas Savant | $118 → $110 | Maintains | Overweight | Get Alert |
02/25/2022 | Buy Now | -5.75% | Baird | Catherine Ramsey | $152 → $100 | Maintains | Outperform | Get Alert |
02/15/2022 | Buy Now | 11.22% | Morgan Stanley | Tejas Savant | $148 → $118 | Maintains | Overweight | Get Alert |
The latest price target for Natera (NASDAQ:NTRA) was reported by Jefferies on June 3, 2024. The analyst firm set a price target for $142.00 expecting NTRA to rise to within 12 months (a possible 33.84% upside). 32 analyst firms have reported ratings in the last year.
The latest analyst rating for Natera (NASDAQ:NTRA) was provided by Jefferies, and Natera initiated their buy rating.
The last upgrade for Natera Inc happened on April 5, 2024 when Bernstein raised their price target to $120. Bernstein previously had a market perform for Natera Inc.
The last downgrade for Natera Inc happened on February 20, 2024 when Raymond James changed their price target from $68 to $85 for Natera Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Natera, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Natera was filed on June 3, 2024 so you should expect the next rating to be made available sometime around June 3, 2025.
While ratings are subjective and will change, the latest Natera (NTRA) rating was a initiated with a price target of $0.00 to $142.00. The current price Natera (NTRA) is trading at is $106.10, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.